Effectiveness of a synthetic human recombinant epidermal growth factor in diabetic patients wound healing: Pilot, double-blind, randomized clinical controlled trial

Título:

Effectiveness of a synthetic human recombinant epidermal growth factor in diabetic patients wound healing: Pilot, double-blind, randomized clinical controlled trial

Autor:

Beatriz Guitton Renaud Baptista de Oliveira

Ano:

2021

Revista:

Wound Repair and Regeneration

ISSN:

1524475X

Idioma:

Inglês

Buscar essa publicação no Google Acadêmico

Publicações com a mesma autoria

A FORMAÇÃO COMO LÍDER SOCIAL NA PRODUÇÃO DE CUIDADOS EM SAÚDE. A POPULAÇÃO EM SITUAÇÃO DE RUA

Avaliação clínica de pacientes com úlceras de perna acompanhados em ambulatório

Blood Cell Count and the Presence or Absence of Infection in Venous Ulcers Treated With Platelet-Rich Plasma

Clinical and Microbiological Outcomes Associated With Use of Platelet-Rich Plasma in Chronic Venous Leg Uclers: A Randomized Controlled Trial.

Nursing and Parkinson?s Disease: A Scoping Review of Worldwide Studies

Rating scales for medication adherence in people living with Parkinson's disease: a systematic review protocol

Ciprofloxacin-Resistant Kerstersia gyiorum Isolated From a Chronic Wound in Brazil: A Case Report

CLINICAL ASPECTS RELATED TO INFECTION IN PATIENTS WITH CHRONIC WOUNDS

CLINICAL ASPECTS RELATED TO INFECTION IN PATIENTS WITH CHRONIC WOUNDS

COST OF TREATMENT AND REDUCTION ACHIEVED BY CHRONIC ULCER IN DIABETIC PATIENTS - A COMPARISON BETWEEN HYDROGEL AND HUMAN RECOMBINANT EPIDERMAL GROWTH FACTOR